Skip to main content
Livermore
Livermore
ZHEN

Two Sigma Advisers, LP

SEC CIK
0001478735
Latest filing
Aug 14, 2026

RCUS holding history

Arcus Biosciences, Inc. in every 13F filed by Two Sigma Advisers, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RCUS overviewAll 13F holders of RCUSFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of RCUS by Two Sigma Advisers, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−285,400−100.0%Sold outHolders
Q3 2025285,400$3.88M<0.1%−10,400−3.5%ReducedHolders
Q2 2025295,800$2.41M<0.1%+171,700+138.4%AddedHolders
Q1 2025124,100$974.2K<0.1%+65,300+111.1%AddedHolders
Q4 202458,800$875.5K<0.1%+15,500+35.8%AddedHolders
Q3 202443,300$662.1K<0.1%+5,200+13.6%AddedHolders
Q2 202438,100$580.3K<0.1%−12,700−25.0%ReducedHolders
Q1 202450,800$959.1K<0.1%+17,200+51.2%AddedHolders
Q4 202333,600$641.8K<0.1%−2,700−7.4%ReducedHolders
Q3 202336,300$651.6K<0.1%−1,300−3.5%ReducedHolders
Q2 202337,600$763.7K<0.1%−77,800−67.4%ReducedHolders
Q1 2023115,400$2.10M<0.1%−56,900−33.0%ReducedHolders
Q4 2022172,300$3.56M<0.1%−2,500−1.4%ReducedHolders
Q3 2022174,800$4.57M<0.1%+40,900+30.5%AddedHolders
Q2 2022133,900$3.39M<0.1%−20,900−13.5%ReducedHolders
Q1 2022154,800$4.88M<0.1%−121,200−43.9%ReducedHolders
Q4 2021276,000$11.2M<0.1%−15,300−5.3%ReducedHolders
Q3 2021291,300$10.2M<0.1%−85,200−22.6%ReducedHolders
Q2 2021376,500$10.3M<0.1%−89,900−19.3%ReducedHolders
Q1 2021466,400$13.1M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.